Nagi Bioscience

📍 Lausanne, Switzerland🗓 Founded 2019👥 15 employees💰 Last funded Nov 2022
Nagi Bioscience is a pioneering high-tech startup developing NextGen laboratory equipment to unlock the full potential of alternatives to animal testing. Located in the heart of the Swiss "Health Valley”, we work for the transformation of biological testing standards providing cutting-edge equipment to achieve faster, scalable, more efficient and ethical methods. Under the motto “in vivo testing at the in vitro scale”, our technologies are accelerating drug development pipelines and introducing new toxicology testing standards revolutionizing pharmaceutical, cosmetic, and agro-chemical industries among others. Our approach? To unlock the full potential of small organisms, such as the well-characterized C. elegans nematode, for high-content screening of substances for safety and efficacy testing.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Nagi Bioscience?
Nagi Bioscience has 1 investors on record on gritt.io, 1 mid-stage.
When did Nagi Bioscience last raise funding?
The most recent investment in Nagi Bioscience recorded on gritt.io was in November 2022.
When was Nagi Bioscience founded?
Nagi Bioscience was founded in 2019.
What industry is Nagi Bioscience in?
Nagi Bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nagi Bioscience based?
Nagi Bioscience is headquartered in Lausanne, Switzerland.